Purixan
Payments companies reported to CMS as associated with Purixan. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Purixan, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Purixan
These are the largest totals companies reported as associated with Purixan. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Faisal Razzaqi | Madera, CA | Pediatric Hematology-Oncology | $58.64 |
| Saunders Hsu | Sacramento, CA | Pediatric Hematology-Oncology | $47.78 |
| Lucy Paskus | Indianapolis, IN | Pediatrics (Nurse Practitioner) | $47.65 |
| Jessica Mollabashy | Indianapolis, IN | Pediatrics (Nurse Practitioner) | $47.65 |
| Bassem Razzouk | Indianapolis, IN | Pediatric Hematology-Oncology | $47.64 |
| Kayleigh Klose | Valhalla, NY | Pediatric Hematology-Oncology | $41.33 |
| Anne Panarella | Hawthorne, NY | Pediatrics (Nurse Practitioner) | $41.32 |
| Marianna De Benedictis | Newark, NJ | Pediatric Hematology-Oncology | $39.80 |
| Anoush Essajanian | Newark, NJ | Pediatrics (Nurse Practitioner) | $39.80 |
| Kelly Folmer | Madera, CA | Pediatrics (Nurse Practitioner) | $36.07 |
Prescribed Purixan?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.